GERMLINE BRCA1 GENE MUTATION
Clinical trials for GERMLINE BRCA1 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new GERMLINE BRCA1 GENE MUTATION trials appear
Sign up with your email to follow new studies for GERMLINE BRCA1 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can new drug combos outsmart PARP resistance in BRCA breast cancer?
Disease control Recruiting nowThis phase 2 trial tests whether adding cediranib or ceralasertib to olaparib can overcome resistance in BRCA-mutated advanced breast cancer. About 60 participants with HER2-negative, BRCA-positive tumors that have progressed on prior therapy will receive one of the two drug comb…
Matched conditions: GERMLINE BRCA1 GENE MUTATION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
App aims to cut cancer risk by cleaning up your diet
Prevention Recruiting nowThis study tests whether a smartphone app, combined with nutrition education, can help people at high risk for cancer eat healthier and reduce their cancer risk. About 170 participants will either get the app or standard advice, and researchers will measure changes in diet qualit…
Matched conditions: GERMLINE BRCA1 GENE MUTATION
Phase: NA • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC